Gabelli & Co Investment Advisers’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-231,076
Closed -$3.63M 525
2022
Q2
$3.63M Buy
231,076
+49,950
+28% +$763K 0.47% 50
2022
Q1
$2.75M Buy
181,126
+7,398
+4% +$113K 0.36% 58
2021
Q4
$2.67M Buy
+173,728
New +$2.29M 0.35% 51

Other funds holding NPTN

Gabelli & Co Investment Advisers's NPTN Position: Q3 2022 in Review

Gabelli & Co Investment Advisers sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 231,076 shares — an estimated $3.63M sold.

Gabelli & Co Investment Advisers first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $3.63M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Gabelli & Co Investment Advisers reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 231,076 NEOPHOTONICS CORP shares in Q3 2022, an estimated $3.63M.
  • Gabelli & Co Investment Advisers first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
  • Gabelli & Co Investment Advisers's NEOPHOTONICS CORP position peaked at $3.63M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.